Checkpoints that control B cell development

Journal of Clinical Investigation

Volumn 125, Issue 6, 2015, Pages 2203-2210

  Melchers, Fritz ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE ANTIGEN RECEPTOR;

ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BONE MARROW; CELL MATURATION; CELL SURVIVAL; EMBRYO DEVELOPMENT; ENZYME INHIBITION; FETUS LIVER; GENE LOCUS; GENE REARRANGEMENT; GENETIC CODE; HEAVY CHAIN; HUMAN; LIGHT CHAIN; LYMPHOCYTE PROLIFERATION; MICROENVIRONMENT; NONHUMAN; PLURIPOTENT HEMATOPOIETIC STEM CELL; PLURIPOTENT STEM CELL LINE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; SPLEEN; ANIMAL; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CELL MOTION; HEMATOPOIETIC STEM CELL; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGY; PATHOLOGY; PLURIPOTENT STEM CELL;

ANIMALS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL MOVEMENT; GENE REARRANGEMENT, B-LYMPHOCYTE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; PLURIPOTENT STEM CELLS; RECEPTORS, ANTIGEN, B-CELL;

EID: 84930392104     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI78083     Document Type: Article

References (94)

1. Rolink AG, Schaniel C, Busslinger M, Nutt SL, Melchers F. Fidelity and infidelity in commitment to B-lymphocyte lineage development. Immunol Rev. 2000;175: 104-111.
2. Rolink AG, Schaniel C, Andersson J, Melchers F. Selection events operating at various stages in B cell development. Curr Opin Immunol. 2001;13(2): 202-207.
3. Melchers F, et al. Repertoire selection by pre-Bcell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells. Immunol Rev. 2000;175: 33-46.
4. Akashi K, et al. Lymphoid development from stem cells and the common lymphocyte progenitors. Cold Spring Harb Symp Quant Biol. 1999;64: 1-12.
5. Cumano A, Ferraz JC, Klaine M, Di Santo JP, Godin I. Intraembryonic, but not yolk sac hematopoietic precursors, isolated before circulation, provide long-term multilineage reconstitution. Immunity. 2001;15(3): 477-485.
6. Ling KW, Dzierzak E. Ontogeny and genetics of the hemato/lymphopoietic system. Curr Opin Immunol. 2002;14(2): 186-191.
7. Godin I, Cumano A. The hare and the tortoise: An embryonic haematopoietic race. Nat Rev Immunol. 2002;2(8): 593-604.
8. Irion S, et al. Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells. Development. 2010;137(17): 2829-2839.
9. Schulz C, et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012;336(6077): 86-90.
10. Böiers C, et al. Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells. Cell Stem Cell. 2013;13(5): 535-548.
11. Tsuneto M, et al. B-cell progenitors and precursors change their microenvironment in fetal liver during early development. Stem Cells. 2013;31(12): 2800-2812.
12. Medvinsky A, Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell. 1996;86(6): 897-906.
13. Ohmura K, et al. Immature multipotent hemopoietic progenitors lacking long-term bone marrowreconstituting activity in the aorta-gonadmesonephros region of murine day 10 fetuses. J Immunol. 2001;166(5): 3290-3296.
14. Cumano A, Godin I. Ontogeny of the hematopoietic system. Annu Rev Immunol. 2007;25: 745-785.
15. Yokomizo T, Ng CE, Osato M, Dzierzak E. Three-dimensional imaging of whole midgestation murine embryos shows an intravascular localization for all hematopoietic clusters. Blood. 2011;117(23): 6132-6134.
16. Sitnicka E, et al. Complementary signaling through flt3 and interleukin-7 receptor a is indispensable for fetal and adult B cell genesis. J Exp Med. 2003;198(10): 1495-1506.
17. Decker T, et al. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis. Immunity. 2009;30(4): 508-520.
18. Revilla-I-Domingo R, et al. The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis. EMBO J. 2012;31(14): 3130-3146.
19. Grawunder U, et al. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity. 1995;3(5): 601-668.
20. Tokoyoda K, Egawa T, Sugiyama T, Choi BI, Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity. 2004;20(6): 707-718.
21. Lu R, Neff NF, Quake SR, Weissman IL. Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding. Nat Biotechnol. 2011;29(10): 928-933.
22. Tokoyoda K, Zehentmeier S, Chang HD, Radbruch A. Organization and maintenance of immunological memory by stroma niches. Eur J Immunol. 2009;39(8): 2095-2099.
23. Tokoyoda K, Hauser AE, Nakayama T, Radbruch A. Organization of immunological memory by bone marrow stroma. Nat Rev Immunol. 2010;10(3): 193-200.
24. Spangrude GJ, et al. Mouse hematopoietic stem cells. Blood. 1991;78(6): 1395-1402.
25. Smith LG, Weissman IL, Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A. 1991;88(7): 2788-2792.
26. Morrison SJ, Uchida N, Weissman IL. The biology ofhematopoietic stem cells. Annu Rev Cell Dev Biol. 1995;11: 35-71.
27. Simsek T, et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell. 2010;7(3): 380-390.
28. Takubo K, et al. Regulation of the HIF-1a level is essential for hematopoietic stem cells. Cell Stem Cell. 2010;7(3): 391-402.
29. Rossi DJ, et al. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle. 2007;6(19): 2371-2376.
30. Visnijk D, et al. Hematopoiesis is severely altered with an induced osteoblast deficiency. Blood. 2004;103(9): 3258-3264.
31. Dougall WC, et al. RANK is essential for osteoclast and lymph node development. Genes Dev. 1999;13(18): 2412-2424.
32. Rolink A, Kudo A, Karasuyama H, Kikuchi Y, Melchers F. Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO J. 1991;10(2): 327-336.
33. Peschon JJ, et al. Early lymphocyte expansion is severely impaired at the transition from MPP to CLP in interleukin 7 receptor-deficient mice. J Exp Med. 1994;180(5): 1955-1960.
34. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL7 as a non-redundant cytokine. J Exp Med. 1995;181(4): 1519-1526.
35. Scheeren FA, et al. Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation. Eur J Immunol. 2010;40(4): 955-965.
36. Haspel MV, et al. Multiple organ-reactive monoclonal autoantibodies. Nature. 1983;304(5921): 73-76.
37. Radic MZ, et al. Residues that mediate DNA binding of autoimmune antibodies. J Immunol. 1993;150(11): 4966-4977.
38. Tiegs SL, Russell DM, Nemazee D. Receptor editing in self-reactive bone marrow B cells. J Exp Med. 1993;177(4): 1009-1020.
39. Wardemann H, Nussenzweig MC. B cell tolerance in humans. Adv Immunol. 2007;95: 83-110.
40. Shimizu T, Mundt C, Licence S, Melchers F, Mertensson IL. VpreB1/VpreB2/? 5 triple-deficient mice show impaired B cell development but functional allelic exclusion of the IgH locus. J Immunol. 2002;168(12): 6286-6293.
41. Schuh W, Meister S, Roth E, Jdck HM. Cutting edge: Signaling and cell surface expression of a mu H chain in the absence of ? 5: A paradigm revisited. J Immunol. 2003;171(7): 3343-3347.
42. Galler GR, et al. Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components. J Exp Med. 2004;199(11): 1523-1532.
43. Grawunder U, et al. In-vitro analyses of mechanisms of B-cell development. Semin Immunol. 1995;7(3): 155-167.
44. Llorian M, Stamataki Z, Hill S, Turner M, Mertensson IL. The PI3K p110? is required for down-regulation of RAG expression in immature B cells. J Immunol. 2007;178(4): 1981-1985.
45. Melchers F. The pre-B-cell receptor: Selector of fitting immunoglobulin heavy chains for the B-cell repertoire. Nat Rev Immunol. 2005;5(7): 578-584.
46. Parker MJ, et al. The pre-B-cell receptor induces silencing of VpreB and ?5 transcription. EMBO J. 2005;24(22): 3895-3905.
47. Karnowski A, et al. Silencing and nuclear repositioning of the ?5 gene locus at the pre-B cell stage requires Aiolos and OBF-1. PLoS One. 2008;3(10): E3568.
48. Kitamura D, et al. A critical role of ?5 protein in B cell development. Cell. 1992;69(5): 823-831.
49. Conley ME. Genes required for B Cell development. J Clin Invest. 2003;112(11): 1636-1638.
50. Bradl H, Wittmann J, Milius D, Vettermann C, Jdck HM. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of ?5 and stroma cell-Associated heparan sulfate. J Immunol. 2003;171(5): 2338-2348.
51. Gauthier L, Rossi B, Roux F, Termine E, Schiff C. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci U S A. 2002;99(20): 13014-13019.
52. Espeli M1, Mancini SJ, Breton C, Poirier F, Schiff C. Impaired B-cell development at the pre-BIIcell stage in galectin-1-deficient mice due to inefficient pre-BII/stromal cell interactions. Blood. 2009;113(23): 5878-5886.
53. Knoll M, et al. The non-Ig parts of the VpreB and ?5 proteins of the surrogate light chain play opposite roles in the surface representation of the precursor B cell receptor. J Immunol. 2012;188(12): 6010-6017.
54. Ohnishi K, Melchers F. The nonimmunoglobulin portion of ?5 mediates cell-Autonomous pre-B cell receptor signaling. Nat Immunol. 2003;4(9): 849-856.
55. Keenan RA, et al. Censoring of autoreactive B cell development by the pre-B cell receptor. Science. 2008;321(5889): 696-699.
56. Almqvist N, Mårtensson IL. The pre-B cell receptor; selecting for or against autoreactivity. Scand J Immunol. 2012;76(3): 256-262.
57. Herzog S, Jumaa H. Self-recognition and clonal selection: Autoreactivity drives the generation of B cells. Curr Opin Immunol. 2012;24(2): 166-172.
58. Melchers F, Yamagami T, Rolink A, Andersson J. Rules for the rearrangement events at the L chain gene loci of the mouse. Adv Exp Med Biol. 2007;596: 63-70.
59. Yamagami T, ten Boekel E, Andersson J, Rolink A, Melchers F. Frequencies of multiple IgL chain gene rearrangements in single normal or kappaL chain-deficient B lineage cells. Immunity. 1999;11(3): 317-322.
60. Flemming A, Brummer T, Reth M, Jumaa H. The adaptor protein SLP-65 acts as a tumor suppressor that limits preB cell expansion. Nat Immunol. 2003;4(1): 38-43.
61. Jumaa H, et al. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature. 2003;423(6938): 452-456.
62. Monroe JG. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat Rev Immunol. 2006;6(4): 283-294.
63. Gay D, Saunders T, Camper S, Weigert M. Receptor editing: An approach by autoreactive B cells to escape tolerance. J Exp Med. 1993;177(4): 999-1008.
64. Nemazee D, Weigert M. Revising B cell receptors. J Exp Med. 2000; 191(11): 1813-1817.
65. Rolink A, Grawunder U, Haasner D, Strasser A, Melchers F. Immature surface Ig+ B cells can continue to rearrange ? and ? L chain gene loci. J Exp Med. 1993;178(4): 1263-1270.
66. Gerdes T, Wabl M. Autoreactivity and allelic inclusion in a B-cell nuclear transfer mouse. Nat Immunol. 2004;5(12): 1282-1287.
67. Li H, Jiang Y, Prak EL, Radic M, Weigert M. Editors and editing of anti-DANN receptors. Immunity. 2001;15(6): 947-957.
68. Doyle CM, Han J, Weigert MG, Prak ET. Consequences of receptor editing at the lambda locus: Multireactivity and light chain secretion. Proc Natl Acad Sci U S A. 2006;103(30): 11246-11269.
69. Witsch EJ, Cao H, Fukuyama H, Weigert M. Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med. 2006;203(7): 1761-1772.
70. Leslie D, Lipsky P, Notkins AL. Autoantibodies as predictors of disease. J Clin Invest. 2001;108(10): 1417-1422.
71. Nemazee D. Does immunological tolerance explain the waste in the B-lymphocyte immune system? Experiment and theory. Ann N Y Acad Sci. 1995;764: 397-401.
72. Rowley B, Tang L, Shinton S, Hayakawa K, Hardy RR. Autoreactive B-1 B cells: Constraints on natural autoantibody B cell antigen receptors. J Autoimmun. 2007;29(4): 236-245.
73. ten Boekel E, Melchers F, Rolink AG. Changes in the V(H) gene repertoire of developing precursor B lymphocytes in mouse bone marrow mediated by the pre-B cell receptor. Immunity. 1997;7(3): 357-368.
74. Rolink AG, Brocker T, Bluethmann H, Kosco- Vilbois MH, Andersson J, Melchers F. Mutations affecting either generation or survival of cells influence the pool size of mature B cells. Immunity. 1999;10(5): 619-628.
75. Rolink AG, Andersson J, Melchers F. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur J Immunol. 1998;28(11): 3738-3748.
76. Allende ML, Tuymetova G, Lee BG, Bonifacino E, Wu YP, Proia RL. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J Exp Med. 2010;207(5): 1113-1124.
77. Simmons S, Ishii M. Sphingosine-1-phosphate: A master regulator of lymphocyte egress and immunity. Arch Immunol Ther Exp (Warsz). 2014;62(2): 103-115.
78. Ohl L, et al. Cooperating mechanisms of CXCR5 and CCR7 in development and organization of secondary lymphoid organs. J Exp Med. 2003;197(9): 1199-1204.
79. Yurasov S, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med. 2005;201(5): 703-711.
80. Carroll MC. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol. 2004;4(10): 825-831.
81. Melchers F, Rolink AR. B cell tolerance - how to make it and how to break it. Curr Top Microbiol Immunol. 2006;305: 1-23.
82. Rolink AG, Tschopp J, Schneider P, Melchers F. BAFF is a survival and maturation factor for mouse B cells. Eur J Immunol. 2002;32(7): 2004-2010.
83. Shlomchik MJ. Sites and stages of autoreactive B cell activation and regulation. Immunity. 2008;28(1): 18-28.
84. Lood C, et al. C1q inhibits immune complexinduced interferon-Alpha production in plasmacytoid dendritic cells: A novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum. 2009;60(10): 3081-3090.
85. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19: 595-621.
86. Hardy RR, Hayakawa K. Positive and negative selection of natural autoreactive B cells. Adv Exp Med Biol. 2012;750: 227-238.
87. Victora GD. SnapShot: The germinal center reaction. Cell. 2014;159(3): 700-700.e1.
88. Oropallo MA, Cerutti A. Germinal center reaction: Antigen affinity and presentation explain it all. Trends Immunol. 2014;35(7): 287-289.
89. Königsberger S, et al. Suboptimal B-cell antigen receptor signaling activity in vivo elicits germinal center counterselection mechanisms. Eur J Immunol. 2015;45(2): 603-611.
90. Heise N, et al. Germinal center B cell maintenance and differentiation are controlled by distinct NF-?B transcription factor subunits. J Exp Med. 2014;211(10): 2103-2118.
91. Brink R. The imperfect control of self-reactive germinal center B cells. Curr Opin Immunol. 2014;28: 97-101.
92. Chan TD, et al. Elimination of germinal-centerderived self-reactive B cells is governed by the location and concentration of self-Antigen. Immunity. 2012;37(5): 893-904.
93. Takemori T, Kaji T, Takahashi Y, Shimoda M, Rajewsky K. Generation of memory B cells inside and outside germinal centers. Eur J Immunol. 2014;44(5): 1258-1264.
94. Spits H, et al. Innate lymphoid cells - A proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2): 145-149.